https://orcid.org/0000-0001-6944-7466
References
- Menon S. India covid: how bad is the second wave? BBC News; May 7, 2021. Available from: https://www.bbc.com/news/56987209/. Accessed July 24, 2021.
- Sen M. Black fungus: these two states account for nearly 42% of India’s 28,252 mucormycosis cases. Mint; June 7, 2021. Available from: https://www.livemint.com/news/india/black-fungus-28-states-see-28-252-mucormycosis-cases-maharashtra-gujarat-among-worst-hit-states-11623069135171.html. Accessed July 24, 2021.
- Indian SARS-CoV-2 Genomics Consortium. Available from: https://dbtindia.gov.in/sites/default/files/Final%20MoHFW_Mutations%20in%20SARS-CoV2_NCDC_Final.pdf. Accessed 24 July, 2021.
- Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr. 2021;15(4):102146. doi:10.1016/j.dsx.2021.05.019
- Pakdel F, Ahmadikia K, Salehi M, et al. Mucormycosis in patients with COVID-19: a cross-sectional descriptive multicentre study from Iran. Mycoses. 2021. doi:10.1111/myc.13334
- Sen M, Honavar SG, Bansal R, et al. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), report 1. Indian J Ophthalmol. 2021;69(7):1670–1692. doi:10.4103/ijo.IJO_1565_21
- Ramaswami A, Sahu AK, Kumar A, et al. COVID-19 associated mucormycosis presenting to the emergency department - an Observational Study of 70 patients. QJM. 2021. doi:10.1093/qjmed/hcab190
- Honavar SG. Code mucor: guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19. Indian J Ophthalmol. 2021;69(6):1361–1365. doi:10.4103/ijo.IJO_1165_21
- Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615. doi:10.1038/s41591-021-01283-z
- Clinical management protocol for COVID-19 in adults. Available from: https://www.mohfw.gov.in/pdf/UpdatedDetailedClinicalManagementProtocolforCOVID19adultsdated24052021.pdf. Accessed July 24, 2021.
- Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54(Suppl 1):S23–S34. doi:10.1093/cid/cir866
- Peterson KL, Wang M, Canalis RF, Abemayor E. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope. 1997;107(7):855–862. doi:10.1097/00005537-199707000-00004
- Sen M, Lahane S, Lahane TP, Parekh R, Honavar SG. Mucor in a viral land: a tale of two pathogens. Indian J Ophthalmol. 2021;69(2):244–252. doi:10.4103/ijo.IJO_3774_20
- Ismaiel WF, Abdelazim MH, Eldsoky I, et al. The impact of COVID-19 outbreak on the incidence of acute invasive fungal rhinosinusitis. Am J Otolaryngol. 2021;42(6):103080. doi:10.1016/j.amjoto.2021.103080
- Hoenigl M, Seidel D, Carvalho A, et al. The emergence of COVID-19 associated mucormycosis: analysis of cases from 18 countries. SSRN. 2021. doi:10.2139/ssrn.3844587
- Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41(5):634–653. doi:10.1086/432579
- Ravani SA, Agrawal GA, Leuva PA, Modi PH, Amin KD. Rise of the phoenix: mucormycosis in COVID-19 times. Indian J Ophthalmol. 2021;69(6):1563–1568. doi:10.4103/ijo.IJO_310_21
- Pal R, Bhadada SK, Misra A. Resurgence of COVID-19 and diabetes in India. Diabetes Metab Syndr. 2021;15(3):1037–1038. doi:10.1016/j.dsx.2021.04.024
- Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet. 2003;362(9398):1828–1838. doi:10.1016/S0140-6736(03)14904-5
- Revannavar SM, P s S, Samaga L, V k V. COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world? BMJ Case Rep. 2021;14(4):e241663. doi:10.1136/bcr-2021-241663
- Bhuyan A. Experts criticise India’s complacency over COVID-19. Lancet. 2021;397(10285):1611–1612. doi:10.1016/S0140-6736(21)00993-4
- Gokulshankar S, Mohanty BK. COVID-19 and black fungus. Asian J Med Health Sci. 2021;4(1):138.
- Brewster CT, Choong J, Thomas C, Wilson D, Moiemen N. Steam inhalation and paediatric burns during the COVID-19 pandemic. Lancet. 2020;395(10238):1690. doi:10.1016/S0140-6736(20)31144-2
- Selarka L, Sharma S, Saini D, et al. Mucormycosis and COVID-19: an epidemic within a pandemic in India. Mycoses. 2021. doi:10.1111/myc.13353
- Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020;185(4):599–606. doi:10.1007/s11046-020-00462-9